Expensive valuations? Half of Nifty50 stocks trade at discount to historical averages
The Nifty50 might have risen 10 per cent in the last six months, but half its constituents are still quoting at valuations below long-term averages. They included , , , Dr Reddy’s Labs and , among others. Many of these stocks are a ‘buy’, with analyst price targets, as per Trendlyne, suggesting 10 per cent … Read more